Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

ERCC1-XPF nuclease: Roles in the repair of DNA interstrand crosslinks and chemotherapy resistance

Bhagwat, Nikhil (2010) ERCC1-XPF nuclease: Roles in the repair of DNA interstrand crosslinks and chemotherapy resistance. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

Primary Text

Download (24MB) | Preview


ERCC1-XPF is a mammalian structure specific endonuclease that incises at the junction of double and 3' single-stranded DNA. ERCC1-XPF and its homologs are implicated in multiple DNA repair pathways including, nucleotide excision repair, interstrand crosslink repair, double strand break repair, repair of AP sites, and telomere maintenance, making it essential for viability. The pleiotropic phenotypes of ERCC1-XPF deficiency in humans, range from the cancer-predisposition syndrome xeroderma pigmentosum to the XPF-ERCC1 progeroid syndrome, a disease of accelerated aging.This document concentrates on dissecting the role of ERCC1-XPF in crosslink repair, elucidating the mechanisms underlying the dramatic phenotypic differences in patients with inherited XPF mutations, and exploring the utility of ERCC1 and XPF as biomarkers of tumor prognosis.Ercc1 and Xpf knockout mice are phenocopies, illustrating that the two proteins function exclusively as a heterodimer. These models present a progeroid phenotype, reflected in some patients with XPF or ERCC1 mutations. We hypothesize that this accelerated aging is consequent on a failure to repair crosslinks, which are highly cytotoxic DNA lesions. The crosslink repair mechanism in animals remains poorly elucidated and the exact relationship of ERCC1-XPF to other players in this pathway, largely unexplored. Herein we show that ERCC1-XPF functions in the same pathway of crosslink repair as the Fanconi anemia proteins and that crosslink unhooking by ERCC1-XPF is required for the efficient binding of FANCD2 to the chromatin.The pleiotropy of phenotypes associated with human ERCC1-XPF deficiency is puzzling. Often, the severity of phenotype does not correlate with the DNA incising ability of the mutant proteins. We show here that the phenotypic heterogeneity is at least partially explained by the mislocalization of mutant proteins to the cytoplasm. The public health importance of this work comes from the increasing interest in the regulation of ERCC1-XPF expression and activity, due to its involvement in DNA repair pathways implicated in the resistance of tumors to platinum-based chemotherapy. A panel of antibodies was tested extensively and optimized for use in clinical measurement of ERCC1-XPF. This will facilitate improved measurement of DNA repair proteins in clinical specimens and greater understanding of the mechanisms of tumor resistance to genotoxic therapy.


Social Networking:
Share |


Item Type: University of Pittsburgh ETD
Status: Unpublished
CreatorsEmailPitt UsernameORCID
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairNiedernhofer, Laura
Committee MemberOpresko, Patriciaplo4@pitt.eduPLO4
Committee MemberFerrell, Robert Erferrell@pitt.eduRFERRELL
Committee MemberGollin, Susannegollin@pitt.eduGOLLIN
Date: 27 January 2010
Date Type: Completion
Defense Date: 18 November 2009
Approval Date: 27 January 2010
Submission Date: 4 December 2009
Access Restriction: 5 year -- Restrict access to University of Pittsburgh for a period of 5 years.
Institution: University of Pittsburgh
Schools and Programs: School of Public Health > Human Genetics
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: ERCC1-XPF; Fanconi anemia; Interstrand crosslink; lung carcinoma; NSCLC; Ovarian cancer; Xeroderma pigmentosum
Other ID:, etd-12042009-164303
Date Deposited: 10 Nov 2011 20:08
Last Modified: 15 Nov 2016 13:53


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item